The heart monitoring platform has boosted its series C round to $37.1m, having reached a 2016 first close that included OSF Healthcare.
US-based patient management technology developer Endotronix yesterday has increased a series C round featuring healthcare provide OSF Healthcare to $37.1m, according to a regulatory filing yesterday.
OSF’s corporate venturing unit, OSF Ventures, was among the participants in the round’s $32m first tranche in 2016. Endotronix has not revealed the identity of the investors that provided the extra funding.
Founded in 2007, Endotronix has created a cloud-based patient management platform that uses an implantable pulmonary artery sensor to facilitate the real-time…
